Take Control with Afrezza® Rapid-acting Inhaled Insulin | Afrezza
Afrezza® lets you inhale your insulin right when food arrives — even unexpectedly — so you can be spontaneous but still in control. Afrezza® lowers your blood sugar fast*, similar to the …
About Afrezza - Ultra Rapid Inhaled Insulin | Afrezza
Once inhaled, Afrezza® passes quickly through your lungs and enters your bloodstream in less than 1 minute. The ultra rapid-acting insulin allows Afrezza® to start controlling blood sugars …
MannKind Corporation - Life more humann
At MannKind, we are committed to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases. Our approach …
Afrezza HCPHome - Afrezza HCP
AFREZZA ® (insulin human) Inhalation Powder is a rapid acting inhaled human insulin indicated to improve glycemic control in adult patients with diabetes mellitus. Limitations of Use: Not …
Paying for Your Prescription & Pharmacy Assistance - Afrezza
MannKind offers several options to help you with the cost of Afrezza®, depending on the type of insurance coverage you have. With the Afrezza® Savings Card, eligible commercially insured …
CDSCO Approves Afrezza® (insulin human) Inhalation Powder in …
5 天之前 · MannKind entered into an exclusive marketing and distribution agreement for Afrezza in India with Cipla Ltd., a global pharmaceutical company, in May 2018. Under the terms of the …
MannKind Corporation Announces FDA Approval of AFREZZA…
AFREZZA ® (uh-FREZZ-uh) is a novel, rapid-acting inhaled insulin therapy indicated to improve glycemic control in adult patients with diabetes mellitus. The product consists of AFREZZA …
CDSCO Approves Afrezza® (insulin human) Inhalation Powder
5 天之前 · “Achieving approval for Afrezza in India, a country with the second highest burden of diabetes worldwide, is an exciting milestone for MannKind and our partner Cipla,” said Michael …
Afrezza® (insulin human) Inhalation Powder | GetAfrezza
What is AFREZZA? AFREZZA is a man-made insulin that is breathed-in through your lungs (inhaled) and is used to control high blood sugar in adults with diabetes mellitus. AFREZZA is …
MannKind's inhaled insulin meets primary efficacy endpoint in study
2024年6月22日 · MannKind today announced positive 17-week results from a Phase 4 U.S. clinical study of its Afrezza inhaled insulin powder. The Danbury, Connecticut-based company …